Multimillion-Dollar Investment Dupont Set to Transform its Production Facility in Ireland
Dupont will be investing millions of dollars to revamp its OxyMem Membrane Aerated Biofilm Reactor (MABR) manufacturing facility in Athlone, Ireland. The move will help to meet the growing demand for MABR across the globe.
Related Vendors

New York/USA – Dupont Water Solutions has recently announced a major transformation of the OxyMem Membrane Aerated Biofilm Reactor (MABR) at its manufacturing facility in Athlone, Ireland. The investment in the facilities and employees at the Athlone site will help meet the increasing global demand for MABR.
OxyMem was the first company to commercialize MABR technology, which provides unique and differentiated performance for secondary wastewater treatment. Dupont acquired OxyMem in 2019, expanding its extensive portfolio of industry-leading water solutions that help produce, purify, and extract some of the world’s most commercially important products.
This multimillion-dollar investment includes additional training for staff based in Athlone. This project is supported by the Irish Government through IDA Ireland.
“As we look to a post-pandemic recovery, ensuring balanced regional enterprise development is key and the announcement of Dupont’s multimillion-dollar investment at their site in Athlone, Ireland is indicative of their continued success in Athlone, and indeed a testament to the Midlands region as a great place to do business,” said Robert Troy, Minister for Trade Promotion, Digital and Company Regulation.
“This investment will allow OxyMem to develop more efficient and more reliable production technology as well as improve our product design to meet the continuously increasing demand by the market,” said Andreas Gorenflo, General Manager of OxyMem. “It is fundamentally important, and it will help us grow the company to meet the increasing global demand for MABR.”
(ID:48086046)